A Republican congressman who was indicted on securities fraud charges reversed course Saturday and said he will end his re-election campaign.
He, his son and another defendant were indicted for alleged illegal trading of stock in Australian biotech firm Innate Immunotherapeutics, where the elder Collins was a board member.
Collins initially said he would seek to clear his name and continue his bid to keep his seat in the November midterm elections.
But on Saturday he released a statement on Twitter saying his campaign is now suspended and he will try to remove his name from the ballot.
Collins said this was in the best interest of his constituents, his party and Trump's conservative agenda.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)